Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure. (TRANS-HF)
A Prospective Randomized Multicenter Controlled Study to Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure With Reduced Ejection Fraction.
Sponsor: Korean Center for Disease Control and Prevention
This NA trial investigates Acute Heart Failure and Heart Failure With Reduced Ejection Fraction and is currently ongoing. Korean Center for Disease Control and Prevention leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jul 2022 — Jun 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Jun 2021 — Jul 2022 [monthly]
Recruiting NA
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Korean Center for Disease Control and Prevention
- Wonju Severance Christian Hospital
For direct contact, visit the study record on ClinicalTrials.gov .